For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

Morrow is now devoting his life to prostate cancer advocacy and urging other younger, high-risk men to get screened early. He ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

Only men with prostate tumors of the luminal B subtype benefited from adding apalutamide to salvage radiation in the phase 2 ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

Researchers report longer progression-free survival when Lutetium-177 was combined with standard radiotherapy for limited ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived ...

A genetic test could guide the use of hormone therapy for men with recurrent prostate cancer after surgery, according to data ...